A mesenchymal perspective of müllerian duct differentiation and regression in Amhr2-lacZ mice
Nelson A. Arango
Program in Genes and Development, The University of Texas, Graduate School of Biomedical Sciences at Houston, Houston, Texas
Department of Molecular Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas
Search for more papers by this authorAkio Kobayashi
Department of Molecular Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas
Program in Developmental Biology, Baylor College of Medicine, Houston, Texas
Search for more papers by this authorYing Wang
Department of Molecular Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas
Search for more papers by this authorSoazik P. Jamin
Department of Molecular Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas
Search for more papers by this authorHu-Hui Lee
Program in Genes and Development, The University of Texas, Graduate School of Biomedical Sciences at Houston, Houston, Texas
Department of Molecular Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas
Search for more papers by this authorGrant D. Orvis
Program in Genes and Development, The University of Texas, Graduate School of Biomedical Sciences at Houston, Houston, Texas
Department of Molecular Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas
Search for more papers by this authorCorresponding Author
Richard R. Behringer
Program in Genes and Development, The University of Texas, Graduate School of Biomedical Sciences at Houston, Houston, Texas
Department of Molecular Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas
Program in Developmental Biology, Baylor College of Medicine, Houston, Texas
Department of Molecular Genetics, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas 77030.Search for more papers by this authorNelson A. Arango
Program in Genes and Development, The University of Texas, Graduate School of Biomedical Sciences at Houston, Houston, Texas
Department of Molecular Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas
Search for more papers by this authorAkio Kobayashi
Department of Molecular Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas
Program in Developmental Biology, Baylor College of Medicine, Houston, Texas
Search for more papers by this authorYing Wang
Department of Molecular Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas
Search for more papers by this authorSoazik P. Jamin
Department of Molecular Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas
Search for more papers by this authorHu-Hui Lee
Program in Genes and Development, The University of Texas, Graduate School of Biomedical Sciences at Houston, Houston, Texas
Department of Molecular Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas
Search for more papers by this authorGrant D. Orvis
Program in Genes and Development, The University of Texas, Graduate School of Biomedical Sciences at Houston, Houston, Texas
Department of Molecular Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas
Search for more papers by this authorCorresponding Author
Richard R. Behringer
Program in Genes and Development, The University of Texas, Graduate School of Biomedical Sciences at Houston, Houston, Texas
Department of Molecular Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas
Program in Developmental Biology, Baylor College of Medicine, Houston, Texas
Department of Molecular Genetics, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas 77030.Search for more papers by this authorAbstract
The Müllerian ducts give rise to the female reproductive tract, including the Fallopian tubes, uterus, cervix, and anterior vagina. In male embryos, the Müllerian ducts regress, preventing the formation of female organs. We introduced the bacterial lacZ gene, encoding β-galactosidase (β-gal), into the AMHR-II locus (Amhr2) by gene targeting in mouse embryonic stem (ES) cells to mark Müllerian duct differentiation and regression. We show that Amhr2-lacZ heterozygotes express β-gal activity in an Amhr2-specific pattern. In the gonads, β-gal activity was detected in Sertoli cells of the testes from 2 weeks after birth, and fetal ovaries and granulosa cells of the adult ovary. β-gal activity was first detected in the rostral mesenchyme of the Müllerian ducts at 12.5 days post coitus (dpc) in both sexes but soon thereafter expression was found along the entire length of the Müllerian ducts with higher levels initially found in males. In females, β-gal activity was restricted to one side of the ductal mesoepithelium, whereas in males β-gal expression encircled the duct. β-gal activity was also detected in the coelomic epithelium at 13.5 and 14.5 dpc. In male embryos, mesenchymal β-gal activity permitted the visualization of the temporal and spatial pattern of Müllerian duct regression. This pattern was similar to that observed using a Müllerian duct mesoepithelium lacZ reporter, indicating a coordinated loss of Müllerian duct mesoepithelium and Amhr2-expressing mesenchyme. Mol. Reprod. Dev. 75: 1154–1162, 2008. © 2008 Wiley-Liss, Inc.
REFERENCES
- Albrecht KH, Eicher EM. 2001. Evidence that Sry is expressed in pre-Sertoli cells and Sertoli and granulosa cells have a common precursor. Dev Biol 240: 92–107.
- Arango NA, Lovell-Badge R, Behringer RR. 1999. Targeted mutagenesis of the endogenous mouse Müllerian inhibiting substance gene promoter: In vivo definition of genetic pathways of vertebrate sexual development. Cell 99: 409–419.
- Austin HB. 1995. DiI analysis of cell migration during Müllerian duct regression. Dev Biol 169: 29–36.
- Baarends WM, Van Helmond MJL, Post M, van der Schoot P, Hoogerbrugge JW, de Winter JP, Uilenbroek J, Karels B, Wilming LG, Carel Meijers JH, Themmen APN, Grootegoed A. 1994. A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and mesenchymal cells adjacent to the Müllerian duct. Development 120: 189–197.
- Baarends WM, Uilenbroek J, Post M, Visser JA, De Rooij DG, Parvinen M, Themmen APN, Grootegoed JA. 1995a. Anti-Müllerian hormone and anti-Müllerian hormone receptor type II receptor messenger ribonucleic acid expression during postnatal testis development in the adult testis of the rat. Endocrinol 136: 5614–5622.
- Baarends WM, Uilenbroek J, Kramer P, Hoogerbrugge JW, Van Leeuwen MJL, Themmen APN, Grootegoed JA. 1995b. Anti-Müllerian hormone and anti-Müllerian hormone receptor type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinol 136: 4951–4962.
- Behringer RR, Finegold MJ, Cate RL. 1994. Müllerian-inhibiting substance function during mammalian sexual development. Cell 79: 415–425.
- Boerboom D, Paquet M, Hsieh M, Liu J, Jamin SP, Behringer RR, Sirois J, Taketo MM, Richards JS. 2005. Misregulated Wnt/beta-catenin signaling leads to ovarian granulosa cell tumor development. Cancer Res 65: 9206–9215.
- Catlin EA, Mangarano TF, Donahoe PK. 1988. Müllerian inhibiting substance depresses accumulation in vitro of disaturated phaphatidylcholine in fetal rat lung. Am J Obstet Gynecol 159: 1299–1303.
- Clarke TR, Hoshiya Y, Yi SE, Liu X, Lyons KM, Donahoe PK. 2001. Mullerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression. Mol Endocrinol 15: 946–959.
- di Clemente N, Wilson C, Faure E, Boussin L, Carmillo P, Tizard R, Picard JY, Vigier B, Josso N, Cate R. 1994. Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone. Mol Endocrinol 8: 1006–1020.
- Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed JA, Themmen AP. 1999. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology 140: 5789–5796.
- Durlinger AL, Gruijters MJ, Kramer P, Karels B, Kumar TR, Matzuk MM, Rose UM, de Jong FH, Uilenbroek JT, Grootegoed JA, Themmen AP. 2001. Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 142: 4891–4899.
- Dyche WJ. 1979. A comparative study of the differentiation and involution of the Müllerian duct and Wolffian duct in the male and female fetal mouse. J Morphol 162: 175–209.
- Faure E, Gouedard L, Imbeaud S, Cate R, Picard J, Josso N, di Clemente N. 1996. Mutant isoforms of the anti-Müllerian hormone type II receptor are not expressed at the cell membrane. J Biol Chem 271: 30571–30575.
- Gouedard L, Chen YG, Thevenet L, Racine C, Borie S, Lamarre I, Josso N, Massague J, di Clemente N. 2000. Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Mullerian hormone and its type II receptor. J Biol Chem 275: 27973–27978.
- Gubbay J, Collignon J, Koopman P, Capel B, Economou A, Munsterberg A, Vivian N, Goodfellow P, Lovell-Badge R. 1990. A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes. Nature 346: 245–250.
- Hacker A, Capel B, Goodfellow P, Lovell-Badge R. 1995. Expression of Sry, the mouse sex determining gene. Development 121: 1603–1614.
- Harry JL, Koopman P, Brennan FE, Graves JA, Renfree MB. 1995. Widespread expression of the testis-determining gene SRY in a marsupial. Nat Genet 11: 347–349.
- Hayashi A, Donahoe PK, Budzik GP, Trelstad RL. 1982. Periductal and matrix glycosaminoglycans in rat Müllerian duct development and regression. Dev Biol 92: 16–26.
- Hutson JM, Donahoe PK. 1986. The hormonal control of testicular descent. Endocr Rev 7: 270–283.
- Imbeaud S, Faure E, Lamarre I, Mattéi M, di Clemente N, Tizard R, Carré-Eusébe D, Belville C, Tragethon L, Tonkin C, Nelson J, McAuliffe M, Bidart J, Lababidi A, Josso N, Cate RL, Picard J. 1995. Insensitivity to anti-Müllerian hormone due to a mutation in the anti-Müllerian hormone receptor. Nat Genet 11: 382–388.
- Imbeaud S, Belville C, Messika-Zeitoun L, Rey R, di Clemente N, Josso N, Picard JL. 1996. A 27 base-pair deletion of the anti-Müllerian type II receptor gene is the most common cause of the persistent Müllerian duct syndrome. Hum Mol Genet 9: 1269–1277.
- Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR. 2002. Requirement of Bmpr1a for Mullerian duct regression during male sexual development. Nat Genet 32: 408–410.
- Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR. 2003. Genetic studies of the AMH/MIS signaling pathway for Mullerian duct regression. Mol Cell Endocrinol 211: 15–19.
- Jorgez CJ, Klysik M, Jamin SP, Behringer RR, Matzuk MM. 2004. Granulosa cell-specific inactivation of follistatin causes female fertility defects. Mol Endocrinol 18: 953–967.
- Josso N, Cate RL, Picard JY, Vigier B, di Clemente N, Wilson C, Imbeaud S, Pepinsky RB, Guerrier D, Boussin L, Legeai L, Carré-Eusèbe D. 1993. Anti-Müllerian hormone: The Jost factor. Recent Prog Horm Res 48: 1–59.
- Josso N, Picard JY, Imbeaud S, di Clemente N, Rey R. 1997. Clinical aspects and molecular genetics of the persistent Müllerian duct syndrome. Clin Endocrinol 47: 137–144.
- Kobayashi A, Behringer RR. 2003. Developmental genetics of the female reproductive tract in mammals. Nat Rev Genet 4: 969–980.
- Kobayashi A, Shawlot W, Kania A, Behringer RR. 2004. Requirement of Lim1 for female reproductive tract development. Development 131: 539–549.
- Koopman P, Gubbay J, Vivian N, Goodfellow P, Lovell-Badge R. 1991. Male development of chromosomally female mice transgenic for Sry. Nature 351: 117–121.
- Lee MM, Seah CC, Masiakos PT, Sottas CM, Preffer FI, Donahoe PK, MacLaughlin DT, Hardy MP. 1999. Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells. Endocrinol 140: 2819–2827.
- Lovell-Badge R, Robertson EJ. 1990. XY female mice resulting from a heritable mutation in the primary testis-determining gene, Tdy. Development 109: 635–646.
- Mishina Y, Rey R, Finegold MJ, Matzuk MM, Josso N, Cate RL, Behringer RR. 1996. Genetic analysis of the Müllerian inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev 10: 2577–2587.
- Mishina Y, Tizard R, Deng JM, Pathak BG, Copeland NG, Jenkins NA, Cate RL, Behringer RR. 1997. Sequence, genomic organization, and chromosomal location of the mouse Mullerian-inhibiting substance type II receptor gene. Biochem Biophys Res Commun 237: 741–746.
- Mishina Y, Whitworth DJ, Racine C, Behringer RR. 1999. High specificity of Mullerian-inhibiting substance signaling in vivo. Endocrinology 140: 2084–2088.
- Münsterberg A, Lovell-Badge R. 1991. Expression of the mouse anti-Müllerian hormone gene suggests a role in both male and female sexual differentiation. Development 113: 613–624.
- Nagy A, Gersenstein M, Vintersten K, Behringer R. 2003. Manipulating the mouse embryo: A laboratory manual. Cold Spring Harbor: CSHL Press.
- Orvis GD, Behringer RR. 2007. Cellular mechanisms of Müllerian duct formation in the mouse. Dev Biol 306: 493–504.
- Parr BA, McMahon AP. 1998. Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a. Nature 395: 707–710.
- Picon R. 1969. Action of the fetal testis on the development in vitro of the Müllerian ducts in the rat. Arch Anat Microsc Morphol Exp 58: 1–19.
- Racine C, Rey R, Forest MG, Louis F, Ferré A, Huhtaniemi I, Josso N, di Clemente N. 1998. Receptors for anti-Müllerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation. Proc Natl Acad Sci USA 95: 594–599.
- Rey R, al-Attar L, Louis F, Jaubert F, Barbet P, Nihoul-Fekete C, Chaussain JL, Josso N. 1996. Testicular dysgenesis does not affect expression of anti-mullerian hormone by Sertoli cells in premeiotic seminiferous tubules. Am J Pathol 148: 1689–1698.
- Roberts LM, Hirokawa Y, Nachtigal MW, Ingraham HA. 1999. Paracrine-mediated apoptosis in reproductive tract development. Dev Biol 208: 110–122.
- Sekido R, Bar I, Narvaez V, Penny G, Lovell-Badge R. 2004. SOX9 is up-regulated by the transient expression of SRY specifically in Sertoli cell precursors. Dev Biol 274: 271–279.
- Sinclair AH, Berta P, Palmer MS, Hawkins JR, Griffiths BL, Smith MJ, Foster JW, Frischauf AM, Lovell-Badge R, Goodfellow PN. 1990. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346: 240–244.
- Teixeira J, Kehas DJ, Antun R, Donahoe PK. 1999. Transcriptional regulation of the rat Mullerian inhibiting substance type II receptor in rodent Leydig cells. Proc Natl Acad Sci USA 96: 13831–13838.
- Trelstad RL, Hayashi A, Hayashi K, Donahoe PK. 1982. The epithelial-mesenchymal interface of the male rat Müllerian duct: Loss of basement membrane integrity and ductal regression. Dev Biol 92: 27–40.
- Tsuji M, Shima H, Yonemura GY, Brody J, Donahoe PK, Cunha GR. 1992. Effects of human recombinant Müllearin inhibiting substance on isolated epithelial and mesenchymal cells during Müllerian duct regression in the rat. Endocrinol 131: 1481–1488.
- Visser JA, Olaso R, Verhoef-Post M, Kramer P, Themmen AP, Ingraham HA. 2001. The serine/threonine transmembrane receptor ALK2 mediates Mullerian inhibiting substance signaling. Mol Endocrinol 15: 936–945.
- Wartenberg H. 1985. Morphological studies on the role of periductal stroma on the regression of the human male Müllerian duct. Anat Embryol 171: 311–323.
- Whitworth DJ, Shaw G, Renfree MB. 1997. Müllerian duct regression in a marsupial, the tammar wallaby. Anat Embryol 196: 39–46.
- Zhan Y, Fujino A, MacLaughlin DT, Manganaro TF, Szotek PP, Arango NA, Teixeira J, Donahoe PK. 2006. Mullerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Mullerian duct regression. Development 133: 2359–2369.